Home

Scott T Reents

CIK 1937048 · EVP, CHIEF FINANCIAL OFFICER · last filed 2026-03-03

Scott T Reents is an EVP, CHIEF FINANCIAL OFFICER who has filed 11 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing shows the insider had shares withheld for taxes covering $5.0M of ABBV on Mar 3, 2026. Across all open-market trades the lifetime net is −$8.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.9M across reported positions. 12 SEC filings were submitted jointly with AbbVie Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.94M

Companies

1

Total Filings

11

Lifetime Open-Market Net

-$8.70M

Filer Profile

Reported Address
1 NORTH WAUKEGAN ROAD
NORTH CHICAGO, IL 60064
Related Filers
AbbVie Inc. — 12 joint filings, latest 2026-03-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ABBV EVP, CHIEF FINANCIAL OFFICER 38,777 $256.46 $9.94M -$8.70M 9 2026-03-03

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-03 ABBV Tax (F) −21,638 -$5.02M EDGAR
2026-02-20 ABBV Grant (A) +48,838 $0 EDGAR
2025-03-18 ABBV Sell (S) −17,644 -$3.75M EDGAR
2025-03-14 ABBV Notice (144) −17,644 -$3.75M EDGAR
2025-03-04 ABBV Tax (F) −10,973 -$2.25M EDGAR
2025-02-18 ABBV Grant (A) +24,763 $0 EDGAR
2024-03-01 ABBV Notice (144) −14,140 -$2.51M EDGAR
2024-03-01 ABBV Mixed −11,634 -$3.72M EDGAR
2024-02-20 ABBV Grant (A) +26,256 $0 EDGAR
2023-03-02 ABBV Mixed −28,625 -$4.40M EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.